Buscar resultados de ensayos clínicos
Langerhans Cell Histiocytosis - 28 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Phase II Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis Condición: Langerhans Cell Histiocytosis Fecha: 2015-04-18 Intervenciones: Drug: Clofarabine Evaluation of response to clofarabine |
Recruiting |
Nombre del estudio: LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis Condición: Langerhans Cell Histiocytosis Fecha: 2014-07-07 Intervenciones:
|
Completed |
Nombre del estudio: Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis Condición: Childhood Langerhans Cell Histiocytosis Fecha: 2006-01-12 Intervenciones:
|
Completed |
Nombre del estudio: Evaluation of Outcome of Adult Pulmonary Langerhans Cell Histiocytosis Based on Lung HRCT and Lung Function Condición: Pulmonary Langerhans Cell Histiocytosis Fecha: 2012-07-25 |
Recruiting |
Nombre del estudio: Methotrexate and Cytosine in Adult Langerhans Cell Histiocytosis Condición: Langerhans Cell Histiocytosis Fecha: 2015-02-09 Intervenciones: Drug: methotrexate Single Group Assignment Other Nam |
Recruiting |
Nombre del estudio: Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH) Condición: Langerhans Cell Histiocytosis Fecha: 2016-01-04 Intervenciones:
|
Recruiting |
Nombre del estudio: Characterization of Pulmonary Langerhans Cell Histiocytosis Condición: Langerhans Cell Histiocytoses Fecha: 2017-03-23 |
Recruiting |
Nombre del estudio: Evaluation of Exercise Capacity and Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis Condición: Langerhans Cell Histiocytosis Fecha: 2016-01-14 |
Recruiting |
Nombre del estudio: A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis Condición: Langerhans Cell Histiocytosis Fecha: 2011-07-12 Intervenciones: Drug: GSK2110183 Drug will be administered as 125 mg capsules once daily. |
Recruiting |
Nombre del estudio: Assessment of Safety of Air Travel in Patients With Pulmonary Langerhans Cell Histiocytosis Condición: Pulmonary Langerhans Cell Histiocytosis Fecha: 2017-02-09 |